封面
市場調查報告書
商品編碼
2008375

間苯二酚市場:依形態、產品等級、銷售管道及應用分類-2026-2032年全球市場預測

Resorcinol Market by Form, Product Grade, Sales Channel, Application - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,間苯二酚市場價值將達到 6.6953 億美元,到 2026 年將成長至 7.0658 億美元,到 2032 年將達到 9.7092 億美元,複合年成長率為 5.45%。

主要市場統計數據
基準年 2025 6.6953億美元
預計年份:2026年 7.0658億美元
預測年份 2032 9.7092億美元
複合年成長率 (%) 5.45%

在不斷變化的法規和永續發展期望下,簡要概述間苯二酚在工業、製藥和攝影等產業的供應鏈中的戰略作用。

間苯二酚是一種小眾但具有重要戰略意義的芳香二羥基化合物,廣泛應用於多個工業和醫藥價值鏈。其獨特的理化性質,如酚類化合物的反應活性和溶解性,使其在從特種農業化學品配方到醫藥中間體,乃至選擇性光化學製程等眾多領域都擁有廣泛的應用需求。間苯二酚既是基礎原料,也是功能性添加劑,並且與面臨日益嚴格的監管審查、不斷成長的永續性期望以及供應鏈結構轉變的終端用戶行業息息相關。

更清潔的合成、更嚴格的監管標準和多元化的供應鏈如何重新定義間苯二酚價值鏈中的競爭重點和供應商選擇標準。

間苯二酚產業正經歷技術、法規和價值鏈結構交會處的多重變革。更環保的合成路線,包括生物催化劑和溶劑減量法,正在降低生產對環境的影響,並為高附加價值產品創造機會。同時,管理體制正在收緊毒理學基準值和雜質限度,提升品管、微量分析和供應商認證流程的重要性。因此,投資於更清潔化學技術和先進製程控制的製造商在與受監管的終端用戶簽訂長期合約方面更具優勢。

本研究評估了 2025 年實施的關稅措施對間苯二酚供應鏈中採購系統重組、供應商認證轉型和生產策略在地化的影響。

美國對間苯二酚及其前驅化學品徵收的關稅政策,進一步增加了採購和成本管理的複雜性。 2025年實施的關稅措施,既對製造商和下游用戶造成了即時的貿易影響,也促使他們採取長期的戰略應對措施。短期來看,對某些進口商品加徵關稅增加了依賴特定貿易流量的企業的收貨成本,導致其採購模式轉向盡可能選擇國內供應商和免稅供應商。對於庫存管理柔軟性有限或利潤率較低的買家而言,這種影響尤其顯著。

針對供應商和買家的細分主導需求,清楚地表明通路、實體形式、產品等級和特殊應用如何決定品質、物流和商業優先事項。

對間苯二酚需求的詳細細分分析揭示了不同管道、劑型、等級和應用領域中清晰的商業性和營運重點。銷售管道的差異——直銷模式與經銷商主導模式——導致了不同的服務期望。直銷協議通常強調長期合約承諾、技術合作和共同開發,而經銷商網路則優先考慮廣泛的供應鏈、快速回應和庫存緩衝,以滿足多樣化的基本客群。這些管道動態影響供應商如何分配商業資源和建構客戶支援系統。

區域比較分析解釋了美洲、歐洲、中東、非洲和亞太地區在採購偏好、監管預期和生產能力方面的差異。

區域趨勢差異顯著,進而影響生產、分銷和合規性的策略重點。在美洲,成熟的工業和製藥行業對需求模式產生影響,重點關注供應商的可靠性、監管文件以及滿足嚴格雜質標準的能力。該地區的籌資策略日益強調就近採購和合約確定性,以降低全球貿易中斷的風險。

垂直整合、專業雜質控制和以服務為導向的經銷夥伴如何為間苯二酚供應商創造競爭優勢。

間苯二酚生態系中各企業的競爭動態反映了其向垂直整合、專業化和服務主導差異化的策略轉型。領先的化學品製造商正投資於下游配方開發和契約製造夥伴關係,以創造附加價值並降低原料貿易流量帶來的風險。同時,特種化學品和醫藥中間體製造商則透過認證、增強分析能力和有針對性的製程改進來實現差異化,從而降低雜質含量並提高批次間一致性。

透過結合清潔生產、提高分析能力、多元化採購和合作經營模式,採取切實可行的策略行動來增強韌性和競爭力。

產業領導企業應推動一系列切實可行的舉措,以確保供應的連續性、合規性和永續成長。首先,優先投資清潔合成技術和減少廢棄物排放,既能降低環境風險,又能擴大對採購標準嚴格的客戶的覆蓋範圍。結合加強分析實驗室和品管體系,這將加快新供應商的認證速度,並有助於交付更高品質的產品。這些技術投資應與供應鏈策略結合,實現跨地區和跨合約類型的採購多元化。平衡成本和韌性至關重要,這可以透過將內部生產能力與契約製造(代工生產)以及與分銷商的關係相結合來實現。

本報告透過透明的分析,結合一手訪談、實地觀察、監管審查和三角驗證技術,為基於證據的結論提供了支持。

本分析整合了旨在確保事實準確性和實用性的初步研究和二手研究。初步研究包括對製造、分銷和終端用戶環節的採購經理、工廠經理以及研發專家進行結構化訪談,以獲取關於品質、物流和商業重點的第一手觀點。此外,盡可能輔以現場考察和流程審查,以便直接觀察製造實務、分析能力和品管系統。

策略整合突顯了品質、永續性和供應韌性如何相互交織,從而決定間苯二酚相關市場的未來成功。

總之,儘管間苯二酚在多種工業和製藥應用領域仍具有重要的戰略意義,但其生產和採購環境正在發生顯著變化。更清潔的生產流程、日益嚴格的監管要求以及不斷變化的貿易政策,都促使品管系統、供應商多元化和技術合作的重要性日益凸顯。能夠展現卓越雜質控制、環境績效和合約可靠性的供應商,更有可能獲得受監管客戶的優先准入權和長期供應合約。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章 間苯二酚市場:依形式分類

  • 粉末
  • 解決方案

第9章 間苯二酚市場:依產品等級分類

  • 工業的
  • 製藥

第10章 間苯二酚市場:依銷售管道分類

  • 直銷
  • 銷售代理

第11章 間苯二酚市場:依應用領域分類

  • 殺蟲劑
    • 消毒劑
    • 除草劑
    • 殺蟲劑
  • 製藥
    • 注射藥物
    • 口服
    • 外用
  • 攝影化學品
    • 底片顯影
    • 印刷化學品
    • X光化學物質

第12章 間苯二酚市場:依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 間苯二酚市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 間苯二酚市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章:美國間苯二酚市場

第16章:中國間苯二酚市場

第17章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Akrochem Corporation
  • Aldon Corporation
  • Amino-Chem Co., Ltd.
  • Ascensus Specialties LLC
  • Atul Ltd.
  • Dynea AS
  • Eastman Chemical Company
  • Emco Dyestuff Pvt. Ltd.
  • Euram Chemicals Ltd.
  • Fengchen Group Co.,Ltd.
  • Glentham Life Sciences Limited
  • Jay Organics Pvt. Ltd.
  • Jayvir Dye Chem
  • Jiangsu Zhongdan Group Co., Ltd.
  • Kautschuk-Group
  • Kraeber & Co GmbH
  • Kumiai Chemical Industry Co., Ltd.
  • LANXESS AG
  • Merck KGaA
  • Mitsui Chemicals Inc.
  • Napp Technologies LLC
  • Otto Chemie Pvt. Ltd.
  • SKW Trostberg GmbH
  • Sumitomo Chemicals Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • TWC Group
  • Ube Industries, Ltd.
  • Yufeng International Co.,Ltd.
Product Code: MRR-C002B1C99604

The Resorcinol Market was valued at USD 669.53 million in 2025 and is projected to grow to USD 706.58 million in 2026, with a CAGR of 5.45%, reaching USD 970.92 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 669.53 million
Estimated Year [2026] USD 706.58 million
Forecast Year [2032] USD 970.92 million
CAGR (%) 5.45%

A concise orientation to resorcinol's strategic role across industrial, pharmaceutical, and photographic supply chains amid evolving regulatory and sustainability expectations

Resorcinol remains a niche yet strategically important aromatic dihydroxy compound used across multiple industrial and pharmaceutical value chains. Its physicochemical profile-characterized by phenolic reactivity and solubility properties-drives demand in applications ranging from specialty agrochemical formulations to pharmaceutical intermediates and selective photographic processes. The substance's role as a building block and functional additive links it intrinsically to end-use industries that are navigating heightened regulatory scrutiny, evolving sustainability expectations, and shifting supply chain structures.

Against this backdrop, stakeholders require a concise synthesis of market dynamics, regulatory pressures, and application-specific developments that influence procurement, formulation chemistry, and downstream product performance. This executive summary consolidates technical, commercial, and strategic insights to support decision-making for manufacturers, suppliers, procurement leaders, and R&D teams. By focusing on practical implications rather than speculative projections, the narrative clarifies how evolving external forces and internal capabilities will shape operational and competitive choices for players engaged with resorcinol-related value chains.

How cleaner synthesis, stricter regulatory thresholds, and supply chain diversification are jointly redefining competitive priorities and supplier selection criteria in resorcinol value chains

The resorcinol landscape is undergoing several transformative shifts that intersect technology, regulation, and supply chain architecture. Advances in greener synthesis routes, including biocatalytic and solvent-minimizing approaches, are reducing the environmental footprint of production and creating opportunities for high-value positioning. Simultaneously, regulatory regimes are tightening toxicological thresholds and impurity limits, which elevates the importance of quality control, trace analytics, and supplier qualification processes. As a result, manufacturers that invest in cleaner chemistries and enhanced process control are better positioned to sustain long-term contracts with regulated end-users.

In parallel, sourcing strategies are recalibrating as buyers prioritize supply continuity and risk mitigation. Diversification away from single-source dependencies is becoming standard practice, prompting investments in regional production capacity and strategic distributor partnerships. These adjustments are accompanied by heightened collaboration between producers and formulators to co-develop cost-optimized, compliant ingredients. Taken together, the technological innovations, regulatory tightening, and supply chain reconfiguration constitute a broad transformation that will favor agile, compliance-focused players capable of coupling technical excellence with resilient commercial models.

Assessing how tariff measures introduced by 2025 have driven procurement reconfiguration, supplier qualification shifts, and strategic production localization in resorcinol supply chains

The tariff landscape affecting resorcinol and precursor chemicals in the United States has introduced an additional layer of complexity to procurement and cost management. Tariff actions implemented through 2025 have prompted both immediate transactional impacts and longer-term strategic responses by manufacturers and downstream users. In the short term, additional duties on certain imports have increased landed costs for organizations reliant on specific trade flows, which in turn has shifted purchasing patterns toward domestic sources or tariff-exempt suppliers where feasible. This effect has been most pronounced for buyers with limited storage flexibility or those operating on tight margin structures.

Over time, stakeholders have adapted by reassessing supplier contracts, accelerating qualification of alternative suppliers, and rebalancing inventory strategies to reduce exposure to tariff volatility. Capital allocation decisions have been influenced as well, with some companies electing to accelerate investments in local production, tolling agreements, or contract manufacturing to bypass tariff-impacted routes. Furthermore, the tariff environment has reinforced the strategic value of granular cost-to-serve analyses and scenario planning, enabling procurement and commercial teams to evaluate the trade-offs between near-term cost impacts and long-term supply resilience. In essence, these tariff measures have catalyzed a more sophisticated and proactive approach to sourcing and supply-chain design for resorcinol-dependent businesses.

Segment-driven imperatives for suppliers and buyers that articulate how channels, physical forms, product grades, and specialized applications determine quality, logistics, and commercial priorities

A nuanced segmentation-based analysis of resorcinol demand reveals distinct commercial and operational priorities across channels, forms, grades, and applications. Sales channel distinctions between direct sales and distributor-led models lead to divergent service expectations: direct sales arrangements typically emphasize long-term contractual commitments, technical collaboration, and co-development, whereas distributor networks prioritize broad availability, responsiveness, and inventory buffering to service diverse customer bases. These channel dynamics influence how suppliers allocate commercial resources and structure customer support capabilities.

Form-based considerations differentiate powder versus solution supply chains, with powder typically offering advantages in transportation efficiency and shelf-life for specific formulations, while solution forms reduce downstream handling and facilitate rapid incorporation into wet-process applications. Product grade segmentation into industrial and pharmaceutical grades imposes contrasting requirements for impurity control, documentation, and regulatory compliance; pharmaceutical-grade resorcinol necessitates rigorous traceability and validated manufacturing practices, whereas industrial grade focuses on cost-effective production and consistent performance for non-critical uses. Application-driven segmentation highlights specialized performance and formulation needs: within agrochemicals, use cases in fungicides, herbicides, and insecticides demand stability under field conditions and compatibility with adjuvants; pharmaceutical applications span injectable, oral, and topical formats, each carrying unique purity, excipient compatibility, and sterilization considerations; photographic chemical uses in film development, printing chemicals, and X-ray processing require controlled reactivity and absence of interfering impurities. Together, these segmentation layers inform product development priorities, quality systems, and go-to-market tactics for suppliers seeking to optimize channel coverage and customer value propositions.

A comparative regional analysis that explains how procurement preferences, regulatory expectations, and production capabilities vary across the Americas, Europe Middle East Africa, and Asia-Pacific

Regional dynamics differ markedly and shape strategic priorities for production, distribution, and regulatory compliance. In the Americas, demand patterns are influenced by mature industrial and pharmaceutical sectors that emphasize supplier reliability, regulatory documentation, and the ability to meet stringent impurity specifications. This region's procurement strategies increasingly favor near-sourcing and contractual security to mitigate exposure to global trade disruptions.

Turning to Europe, the Middle East, and Africa, regulatory harmonization and sustainability mandates are significant drivers of supplier differentiation. Firms operating in this composite region are expected to demonstrate environmental performance, supply chain transparency, and adherence to evolving chemical management frameworks. These expectations frequently translate into premium pricing for compliant suppliers and heightened scrutiny of raw material provenance.

Asia-Pacific remains a dual-force environment, exhibiting both high-volume production capability and rapidly growing specialized demand. Manufacturers in this region play a central role in global supply chains due to established chemical production infrastructure, while regional buyers are accelerating technical sophistication and regulatory alignment. Consequently, companies operating across these regions must calibrate their commercial models to balance cost competitiveness, local compliance, and the need for robust logistics networks that can respond to variable demand profiles and trade policy shifts.

How vertical integration, specialization in impurity control, and service-oriented distributor partnerships are shaping competitive advantage among resorcinol suppliers

Competitive dynamics among companies in the resorcinol ecosystem reflect strategic moves toward vertical integration, specialization, and service-led differentiation. Leading chemical producers are investing in downstream formulations and tolling partnerships to capture incremental value and to de-risk exposure to fluctuating raw material trade flows. At the same time, specialty chemical manufacturers and pharmaceutical intermediates producers are differentiating through certifications, enhanced analytical capabilities, and targeted process improvements that reduce impurity burdens and improve batch-to-batch consistency.

Distribution partners continue to play a pivotal role by offering logistical scale, regional reach, and inventory management services that are particularly valuable for customers with variable consumption patterns. Additionally, contract manufacturers and toll processors have emerged as important enablers for clients that require flexible capacity without committing to capital-intensive expansions. Collaboration between technical teams across supplier and customer organizations is becoming a competitive advantage, as it shortens development cycles and aligns product specifications more closely with end-use performance requirements. Overall, firms that combine operational excellence with proactive regulatory alignment and customer-focused service models are best positioned to capture preferred-supplier status in a complex landscape.

Practical strategic actions that combine cleaner production, analytics upgrades, diversified sourcing, and collaborative commercial models to strengthen resilience and competitive positioning

Industry leaders should pursue a set of pragmatic actions to secure supply continuity, regulatory compliance, and sustainable growth. First, prioritizing investments in cleaner synthesis and waste minimization will reduce environmental liabilities while opening doors to customers with stringent procurement standards. Complementary to this, strengthening analytical laboratories and quality systems will enable faster qualification of new suppliers and support higher-grade product offerings. These technical investments must be paired with supply-chain strategies that diversify sourcing across geographies and contract types, combining owned capacity with tolling and distributor relationships to balance cost and resilience.

Commercially, firms should deepen technical partnerships with key customers to co-develop formulations that lower downstream processing costs and enhance performance. Proactive engagement with regulatory bodies and participation in standards-setting initiatives will help anticipate compliance shifts and reduce time-to-market friction. Finally, embedding scenario-based procurement planning and dynamic cost-to-serve modeling into commercial routines will equip leaders to respond quickly to trade policy changes, input-cost shocks, or demand realignments, thereby protecting margins and customer relationships over the medium term.

A transparent synthesis of primary interviews, site observations, regulatory review, and triangulation techniques that underpins the report's evidence-based conclusions

This analysis synthesizes primary and secondary research designed to ensure factual rigor and actionable relevance. Primary inputs include structured interviews with procurement leaders, plant managers, and R&D experts across manufacturing, distribution, and end-use segments to capture firsthand perspectives on quality, logistics, and commercial priorities. These engagements were complemented by site visits and process reviews where feasible, enabling direct observation of manufacturing practices, analytical capabilities, and quality systems.

Secondary research encompassed regulatory documentation, technical literature, and publicly available trade data to validate supply chain linkages and to contextualize policy impacts. Findings were triangulated by cross-referencing interview insights with technical standards and documented trade measures, and then subjected to internal quality control through peer review and methodological checks. Throughout, emphasis was placed on evidence-based conclusions and practical implications rather than speculative forecasts, ensuring that the research supports immediate decision-making and strategic planning.

A strategic synthesis highlighting how quality, sustainability, and supply resilience converge to determine future success in resorcinol-related markets

In conclusion, resorcinol's strategic importance persists across multiple industrial and pharmaceutical applications, yet the environment in which it is produced and procured is shifting materially. Cleaner production pathways, heightened regulatory expectations, and trade policy developments have combined to elevate the importance of quality systems, supplier diversification, and technical collaboration. Suppliers that can demonstrate superior impurity control, environmental performance, and contractual reliability will gain preferential access to regulated customers and long-term supply agreements.

Moving forward, decision-makers should focus on integrating technical investments with commercial strategies that prioritize flexibility and transparency. By doing so, organizations can mitigate exposure to tariff-driven cost pressures, navigate evolving regulatory landscapes, and capture value through differentiated product grades and service models. The synthesis provided here offers a practical basis for those strategic choices, highlighting where operational changes and commercial investments can deliver the most immediate and durable benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Resorcinol Market, by Form

  • 8.1. Powder
  • 8.2. Solution

9. Resorcinol Market, by Product Grade

  • 9.1. Industrial
  • 9.2. Pharmaceutical

10. Resorcinol Market, by Sales Channel

  • 10.1. Direct Sales
  • 10.2. Distributors

11. Resorcinol Market, by Application

  • 11.1. Agrochemicals
    • 11.1.1. Fungicides
    • 11.1.2. Herbicides
    • 11.1.3. Insecticides
  • 11.2. Pharmaceuticals
    • 11.2.1. Injectable
    • 11.2.2. Oral
    • 11.2.3. Topical
  • 11.3. Photographic Chemicals
    • 11.3.1. Film Development
    • 11.3.2. Printing Chemicals
    • 11.3.3. X-Ray Chemicals

12. Resorcinol Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Resorcinol Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Resorcinol Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Resorcinol Market

16. China Resorcinol Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Akrochem Corporation
  • 17.6. Aldon Corporation
  • 17.7. Amino-Chem Co., Ltd.
  • 17.8. Ascensus Specialties LLC
  • 17.9. Atul Ltd.
  • 17.10. Dynea AS
  • 17.11. Eastman Chemical Company
  • 17.12. Emco Dyestuff Pvt. Ltd.
  • 17.13. Euram Chemicals Ltd.
  • 17.14. Fengchen Group Co.,Ltd.
  • 17.15. Glentham Life Sciences Limited
  • 17.16. Jay Organics Pvt. Ltd.
  • 17.17. Jayvir Dye Chem
  • 17.18. Jiangsu Zhongdan Group Co., Ltd.
  • 17.19. Kautschuk-Group
  • 17.20. Kraeber & Co GmbH
  • 17.21. Kumiai Chemical Industry Co., Ltd.
  • 17.22. LANXESS AG
  • 17.23. Merck KGaA
  • 17.24. Mitsui Chemicals Inc.
  • 17.25. Napp Technologies LLC
  • 17.26. Otto Chemie Pvt. Ltd.
  • 17.27. SKW Trostberg GmbH
  • 17.28. Sumitomo Chemicals Co. Ltd.
  • 17.29. Thermo Fisher Scientific Inc.
  • 17.30. Tokyo Chemical Industry Co., Ltd.
  • 17.31. TWC Group
  • 17.32. Ube Industries, Ltd.
  • 17.33. Yufeng International Co.,Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESORCINOL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESORCINOL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RESORCINOL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RESORCINOL MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RESORCINOL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESORCINOL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RESORCINOL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESORCINOL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RESORCINOL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RESORCINOL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESORCINOL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RESORCINOL MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RESORCINOL MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESORCINOL MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RESORCINOL MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESORCINOL MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RESORCINOL MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESORCINOL MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESORCINOL MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESORCINOL MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESORCINOL MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RESORCINOL MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESORCINOL MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RESORCINOL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESORCINOL MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RESORCINOL MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESORCINOL MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESORCINOL MARKET SIZE, BY AGROCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESORCINOL MARKET SIZE, BY AGROCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESORCINOL MARKET SIZE, BY FUNGICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESORCINOL MARKET SIZE, BY FUNGICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESORCINOL MARKET SIZE, BY FUNGICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESORCINOL MARKET SIZE, BY HERBICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESORCINOL MARKET SIZE, BY HERBICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESORCINOL MARKET SIZE, BY HERBICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESORCINOL MARKET SIZE, BY INSECTICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESORCINOL MARKET SIZE, BY INSECTICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESORCINOL MARKET SIZE, BY INSECTICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESORCINOL MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RESORCINOL MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESORCINOL MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESORCINOL MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESORCINOL MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RESORCINOL MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESORCINOL MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RESORCINOL MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESORCINOL MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESORCINOL MARKET SIZE, BY FILM DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESORCINOL MARKET SIZE, BY FILM DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESORCINOL MARKET SIZE, BY FILM DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESORCINOL MARKET SIZE, BY PRINTING CHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESORCINOL MARKET SIZE, BY PRINTING CHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESORCINOL MARKET SIZE, BY PRINTING CHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESORCINOL MARKET SIZE, BY X-RAY CHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESORCINOL MARKET SIZE, BY X-RAY CHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESORCINOL MARKET SIZE, BY X-RAY CHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESORCINOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS RESORCINOL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL RESORCINOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 139. GCC RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. GCC RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 143. GCC RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 163. G7 RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. G7 RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 167. G7 RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 169. NATO RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 171. NATO RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. NATO RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 175. NATO RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL RESORCINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES RESORCINOL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA RESORCINOL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA RESORCINOL MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA RESORCINOL MARKET SIZE, BY PRODUCT GRADE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA RESORCINOL MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA RESORCINOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA RESORCINOL MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA RESORCINOL MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA RESORCINOL MARKET SIZE, BY PHOTOGRAPHIC CHEMICALS, 2018-2032 (USD MILLION)